<DOC>
	<DOCNO>NCT02427360</DOCNO>
	<brief_summary>This retrospective non randomize cohort evaluate efficacy MAS3 patient uncomplicated P. falciparum malaria mixed infection ( P. falciparum + non-falciparum specie ) . The review patient ' record blood sample perform patient treated clinic Shoklo Malaria Research Unit period January 2003 December 2013 .</brief_summary>
	<brief_title>Evaluating Efficacy Artesunate-mefloquine Relative Roles Resistance Genetic Markers</brief_title>
	<detailed_description>The objective study evaluate Day 42 PCR adjusted cure rate mefloquine-artesunate ( MAS3 ) patient P. falciparum Study procedure Clinic patient record log book review follow clinical information extract : vital sign especially temperature , clinical sign symptom , blood slide haematocrit result finding physical examination ( anaemia , jaundice , liver , spleen etc ) . As routine , data record clinic patient record malaria smear microscopy logbook accordingly ( regard source document analysis ) . These source document review stored specimen analyse get permission Director Shoklo Malaria Research Unit , University Oxford Tropical Research Ethical Committee ( OxTREC ) Faculty Tropical Medicine Ethics Committee ( FTMEC ) . These data extract transcribed case record form enter Microsoft access . During data extraction , unique ID assign patient whereas patient ' name neither enter database disclose analysis process ( ie : data anonymised ) .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Patients age sex receive treatment uncomplicated malaria follow January 2003 December 2013 Symptomatic malaria infection , i.e . history fever tympanic temperature ≥37.5°c Microscopically confirm asexual stage P. falciparum ≥ 5/500 WBC ( alone mixed non P. falciparum specie ) Received fully supervise treatment mefloquineartesunate Pregnant woman P. falciparum asexual stage parasitaemia great equal 4 % red blood cell Signs symptom indicative severe malaria29 Mefloquine treatment within 60 day precede current episode malaria Splenectomy Patients exclude efficacy analysis n't finish 3 day treatment mefloquine artesunate still keep intentiontotreat population .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Retrospective Studies</keyword>
	<keyword>Clinical Efficacy</keyword>
</DOC>